Osteoporosis Testing Market
Osteoporosis Testing Market Study by Dexa Scan, FRAX Tool, CT Scans, X rays, and Ultrasound for Hospitals, Orthopedic Clinics, and Ambulatory Surgical Centers From 2024 to 2034
Analysis of Osteoporosis Testing Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Osteoporosis Testing Market Outlook (2024 to 2034)
The global osteoporosis testing market is currently valued at US$ 1.88 billion in 2024. The market is forecasted to expand at a CAGR of 13.2% to reach US$ 6.52 billion by 2034.
Osteoporosis is a disorder associated with an increased risk of fractures in males, women going through menopause, the elderly, and other individuals facing certain nutrient deficiencies. Patients with osteoporosis typically shatter their wrists, hips, forearms, spines, and hips. It is therefore referred to as the metabolic disorder that lowers bone mineral density and causes fractures.
Therefore, the market for osteoporosis medications is growing as the condition is becoming more common. Women are primarily affected by osteoporosis. The majority of persons with osteoporosis are thought to be over 65, with 5% of males and 25% of women, according to the International Osteoporosis Foundation.
The market for osteoporosis testing is expanding due to increased osteoporosis cases. Several factors, such as its quick response time and reduced cost compared to traditional procedures are creating prospects for market players. Osteoporosis testing is growing in popularity as a routine check for the disease, and it has several applications in tracking and assessing bone density, which further help in leading a healthy life.
Rheumatoid arthritis, a family history of osteoporosis, and long-term use of drugs that alter hormone levels or bone strength, such as oral steroids, are some additional variables that raise the risk of osteoporosis. Furthermore, rising healthcare spending on drug research and discovery, along with increasing public knowledge of the medications available to treat osteoporosis, are the key drivers driving the market growth over the projected period.
| Report Attribute | Detail |
|---|---|
| Osteoporosis Testing Market Size (2024E) | US$ 1.88 Billion |
| Forecasted Market Value (2034F) | US$ 6.52 Billion |
| Global Market Growth Rate (2024 to 2034) | 13.2% CAGR |
| North America Market Value (2024E) | US$ 652.17 Million |
| Mexico Market Value (2034F) | US$ 178.13 Million |
| Hospitals Segment Growth Rate (2024 to 2034) | 13.6% CAGR |
| Canada Market Value (2034F) | US$ 316.83 Million |
| Key Companies Profiled | Abbott Laboratories; BeamMed Ltd.; CooperSurgical Inc.; Danaher Corporation; GE Healthcare; Hologic Plc.; Roche Holding AG; Sectra AB. |
Osteoporosis testing is a type of procedure that allows physicians/rheumatologists to examine bone density in the outpatient clinic. Osteoporosis is a disease identified by thinning and deterioration of bone tissue with loss of calcification and density. The severity of osteoporosis increases over time.
This causes the bone to become brittle and increasingly porous. Women and older adults are more at risk of being affected by osteoporosis. Heredity, low body weight, and chronic use of certain medications (steroids) are also risk factors for the disease.
Lifting, bending, bumping, and sneezing also cause bone to break in people affected by osteoporosis. According to the osteoporosis testing industry outlook, osteoporosis testing helps to estimate the density of bones and the chances of breaking a bone.
Osteoporosis testing checks the bone density; physicians usually refer to bone densitometer. Bone loss occurs because of different disorders, including rheumatoid arthritis, hyperparathyroidism, chronic kidney disease, multiple myeloma, or drugs, such as anti-epileptics and glucocorticoids.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Osteoporosis Testing Market: Drivers and Restraints
As opined in the osteoporosis testing industry analysis by Fact.MR, the growing number of incidences of osteoporosis is driving the growth of the market. Rapid turnaround time and lower cost of procedure over conventional methods also fuel the growth of the market. In addition, the varied applications of Osteoporosis testing procedures in analyzing/tracking bone density and increasing adoption in a routine check of osteoporosis are harnessing the growth of the market.
Osteoporosis testing is a technological integration of existing bone densitometer or scanning techniques that have further reduced the risk associated with kyphoplasty or vertebroplasty procedures. However, potential side effects associated with kyphoplasty or vertebroplasty procedures, such as nosebleeds, fainting, blood pressure fluctuation, or reactions due to the anesthesia hamper the adoption rate. Lack of awareness of joint pain and osteoporosis and limitations of DEXA leads to restraining the market growth, as stated in the newly published osteoporosis testing industry outlook.
Osteoporosis Testing Market: Overview
According to the International Osteoporosis Foundation, globally, 8.9 million people suffer from fractures annually because of osteoporosis. Approximately one-tenth of 60-year-olds, one-fifth of women aged 70, two-fifths of 80-year-old women, and two-thirds of women aged 90.
As mentioned in the osteoporosis testing industry analysis, osteoporosis affects an estimated 75 million people in Europe, North America, and Japan. An increasing number of patients have been visiting for osteoporosis testing, and its growing demand exhibits lucrative growth opportunities for companies investing in this market.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Osteoporosis Testing Market: Regional Outlook
Geographically, the global market is segmented into regions viz. North America, Europe, Asia-Pacific excluding Japan, Middle East and Africa, and Japan. North America & Europe region exhibit healthy growth in terms of revenue due to increased awareness of checking osteoporosis as a part of routine checkups.
The lower cost of the procedure compared with other alternative treatments and the low risk associated with the procedure is boosting the growth of the market. The developing cluster of North America, Asia, and Africa region is likely to gain momentum in late 2020. Patient populations suffering from osteoporosis testing are mostly prescribed alternative medicine treatment in the region, which results in chronic side effects due to treatment.
Osteoporosis Testing Market: Key Players
Some of the players identified in the market include GE Healthcare, Merck & Company, B.M.Tech. Worldwide Co. Ltd, DMS Imaging, Swissray, Hologic Inc. Pfizer Inc., CompuMed, Inc., and Eli Lilly and Company
The report is a compilation of first-hand information, qualitative and quantitative assessments by industry analysts, and inputs from industry experts and industry participants across the value chain. The report provides an in-depth analysis of parent market trends, macro-economic indicators, and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
The report covers an exhaustive analysis on :
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Technology
- Value Chain
Regional analysis includes :
- North America (U.S., Canada)
- Latin America (Argentina, Mexico, Brazil)
- Europe (Germany, Italy, UK, Spain, France, Russia, Poland)
- Asia Pacific Excluding Japan (India, Australia & New Zealand, China, ASEAN)
- Japan
- Middle East and Africa (GCC, South Africa, Rest Of MEA)
Report Highlights :
- Detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint.
Segmentation of the Osteoporosis Testing Market Research
-
By Product Type :
- Dexa-Scan
- FRAX tool
- CT scans
- X-rays
- Ultrasounds
-
By End User :
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Centers
-
By Region :
- Northeast
- Southeast
- West
- Southwest
- Midwest
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Product Type
- 6.2. End User
- 7. Global Market Analysis and Forecast, By Product Type
- 7.1. Dexa-Scan
- 7.2. FRAX tool
- 7.3. CT scans
- 7.4. X-rays
- 7.5. Ultrasounds
- 8. Global Market Analysis and Forecast, By End User
- 8.1. Hospitals
- 8.2. Orthopedic Clinics
- 8.3. Ambulatory Surgical Centers
- 9. Global Market Analysis and Forecast, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Western Europe
- 9.4. Eastern Europe
- 9.5. East Asia
- 9.6. South Asia & Pacific
- 9.7. MEA
- 10. North America Sales Analysis and Forecast, by Key Segments and Countries
- 11. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 12. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 13. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 14. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 15. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 16. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 17. Sales Forecast by Product Type and End User for 30 Countries
- 18. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 19. Company Profile
- 19.1. E Healthcare
- 19.2. Merck & Company
- 19.3. B.M.Tech. Worldwide Co. Ltd
- 19.4. DMS Imaging
- 19.5. Swissray
- 19.6. Hologic Inc.
- 19.7. Pfizer Inc.
- 19.8. CompuMed Inc.
- 19.9. Eli Lilly and Company
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market US$ Mn Forecast by Region
Table 02: Global Market US$ Mn Forecast by Product Type
Table 03: Global Market US$ Mn Forecast by End User
Table 04: North America Market US$ Mn Forecast by Country
Table 05: North America Market US$ Mn Forecast by Product Type
Table 06: North America Market US$ Mn Forecast by End User
Table 07: Latin America Market US$ Mn Forecast by Country
Table 08: Latin America Market US$ Mn Forecast by Product Type
Table 09: Latin America Market US$ Mn Forecast by End User
Table 10: Western Europe Market US$ Mn Forecast by Country
Table 11: Western Europe Market US$ Mn Forecast by Product Type
Table 12: Western Europe Market US$ Mn Forecast by End User
Table 13: Eastern Europe Market US$ Mn Forecast by Country
Table 14: Eastern Europe Market US$ Mn Forecast by Product Type
Table 15: Eastern Europe Market US$ Mn Forecast by End User
Table 16: East Asia Market US$ Mn Forecast by Country
Table 17: East Asia Market US$ Mn Forecast by Product Type
Table 18: East Asia Market US$ Mn Forecast by End User
Table 19: South Asia & Pacific Market US$ Mn Forecast by Country
Table 20: South Asia & Pacific Market US$ Mn Forecast by Product Type
Table 21: South Asia & Pacific Market US$ Mn Forecast by End User
Table 22: MEA Market US$ Mn Forecast by Country
Table 23: MEA Market US$ Mn Forecast by Product Type
Table 24: MEA Market US$ Mn Forecast by End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 02: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 03: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 04: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 05: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 06: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 07: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 08: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 09: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 10: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 11: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 12: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 14: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 15: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 16: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 17: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 18: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 19: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 20: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 21: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 22: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 23: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by End User
Figure 24: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is driving the demand outlook for the osteoporosis testing market?
A growing number of incidences of osteoporosis are driving the growth of the osteoporosis testing market.
Where will the growth spearhead in the market?
North America and South Asia & Pacific are analyzed to witness noteworthy growth over the forecast period.
Which are the top players in the market?
The key companies are GE Healthcare, Merck & Company, B.M.Tech, Worldwide Co. Ltd, DMS Imaging, Swissray, and CompuMed, Inc.
Osteoporosis Testing Market